日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗辅助治疗IIB期或IIC期黑色素瘤:一项随机临床试验的二次分析

Leachman, Sancy A; Luke, Jason J; Ascierto, Paolo A; Long, Georgina V; Khattak, Muhammad A; Rutkowski, Piotr; Xu, Zhi Jin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Schadendorf, Dirk

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection

全球癌症危机:日益加重的负担、日益加剧的不平等以及预防和早期检测举措综述

Balch, Charles M; Liao, Ning; Lam, Dennis S C; Weitzel, Jeffrey N; Xu, Rui-Hua; Attard, Gerhardt; Bunn, Paul A; Eggermont, Alexander M M; He, Jie; Kitagawa, Yuko; Lim, Soon Thye; Cazap, Eduardo; Esquivel, Bernard; Fan, Xianqun; Chow, Louis W C; Liu, Edward S F; Said, Hector Martinez; Niederhuber, John E; Rubio, Isabel T; Zaghloul, Ashraf Saad; Arrieta, Oscar G; Audisio, Riccardo A; Beets, Geerard L; Coimbra, Felipe J F; Gallardo, Jorge E; Garber, Judy E; Gronchi, Alessandro; Heinemann, Volker; Kurian, Allison W; Mutebi, Miriam; Mori, Masaki; Olopade, Funmi I; Rutkowski, Piotr; Saleh, Mansoor; Sanchez, William M; Sawaya, Raymond; Thompson, John F; Tumusiime, Gerald; Vallejos, Carlos S; Whiteman, David C; Wu, YiLong; Yawe, King-David T; Zahrani, Nayef Awad Al; Zoras, Odysseas; Arun, Banu K; Fabian, Carol J; Gershenwald, Jeffrey E; Gradishar, William J; He, Jin; Kimberg, V Suzanne; Lam, Ronald M K; Lee, Victor H F; Lorusso, Domenica; Mok, Tony S K; Perrier, N D; Rugo, Hope S; Ulrich, Cornelia; Are, Chandrakanth; Vignat, J; Soerjomataram, I

Immunosurveillance in clinical cancer management

免疫监视在临床癌症管理中的应用

Kroemer, Guido; Chan, Timothy A; Eggermont, Alexander M M; Galluzzi, Lorenzo

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

随机辅助树突状细胞MIND-DC试验中,微生物群相关代谢重编程对黑色素瘤患者临床结局的影响

Carolina Alves Costa Silva # ,Gianmarco Piccinno # ,Déborah Suissa # ,Mélanie Bourgin # ,Gerty Schreibelt # ,Sylvère Durand ,Roxanne Birebent ,Marine Fidelle ,Cissé Sow ,Fanny Aprahamian ,Paolo Manghi ,Michal Punčochář ,Francesco Asnicar ,Federica Pinto ,Federica Armanini ,Safae Terrisse ,Bertrand Routy ,Damien Drubay ,Alexander M M Eggermont ,Guido Kroemer ,Nicola Segata ,Laurence Zitvogel ,Lisa Derosa ,Kalijn F Bol ,I Jolanda M de Vries

Engaging European society at the forefront of cancer research and care: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto

让欧洲社会参与到癌症研究和治疗的前沿:第五届加戈欧洲科学政策会议的讨论如何促成了《海德堡宣言》的诞生

Baumann, Michael; Celis, Julio; Ringborg, Ulrik; Heitor, Manuel; Berns, Anton; Albreht, Tit; Arabadjiev, Jeliazko; Boutros, Michael; Brandenburg, Mario; Canhao, Helena; Carneiro, Fatima; Chomienne, Christine; De Lorenzo, Francesco; Eggermont, Alexander M M; Font, Angel; Garralda, Elena; Goulart, Margarida; Henrique, Rui; Lawler, Mark; Maier-Hein, Lena; Meunier, Francoise; Oberst, Simon; Oliveira, Pedro; Papatriantafyllou, Maria; Schüz, Joachim; Solary, Eric; Valencia, Alfonso; Vargas, Rosalia; Weiderpass, Elisabete; Wilking, Nils

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

免疫相关不良事件与接受帕博利珠单抗或安慰剂治疗的III期黑色素瘤患者的无复发生存期之间的关联:一项随机临床试验的二次分析

Eggermont, Alexander M M; Kicinski, Michal; Blank, Christian U; Mandala, Mario; Long, Georgina V; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; van Akkooi, Alexander; Robert, Caroline; Suciu, Stefan

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

利用临床病理学和基因表达模型识别I/IIA期黑色素瘤患者中疾病复发高风险人群

Eggermont, Alexander M M; Bellomo, Domenico; Arias-Mejias, Suzette M; Quattrocchi, Enrica; Sominidi-Damodaran, Sindhuja; Bridges, Alina G; Lehman, Julia S; Hieken, Tina J; Jakub, James W; Murphree, Dennis H; Pittelkow, Mark R; Sluzevich, Jason C; Cappel, Mark A; Bagaria, Sanjay P; Perniciaro, Charles; Tjien-Fooh, Félicia J; Rentroia-Pacheco, Barbara; Wever, Renske; van Vliet, Martin H; Dwarkasing, Jvalini; Meves, Alexander

Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view

抗CD19嵌合抗原受体T细胞疗法治疗儿童复发/难治性B细胞急性淋巴细胞白血病的成本效益分析:社会视角

Thielen, Frederick W; van Dongen-Leunis, Annemieke; Arons, Alexander M M; Ladestein, Judith R; Hoogerbrugge, Peter M; Uyl-de Groot, Carin A

Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas

溃疡性黑色素瘤中肿瘤内 HLA I 类和肿瘤周围 Mx1 的上调

Daniëlle Verver, Vichnou Poirier-Colame, Gorana Tomasic, Khadija Cherif-Rebai, Dirk J Grunhagen, Cornelis Verhoef, Stefan Suciu, Caroline Robert, Laurence Zitvogel, Alexander M M Eggermont

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial

在EORTC18961试验中,对II期黑色素瘤患者针对肿瘤相关抗原的体液免疫反应进行多重微珠检测

Michels, Judith; Becker, Natalia; Suciu, Stefan; Kaiser, Iris; Benner, Axel; Kosaloglu-Yalcin, Zeynep; Agoussi, Sandrine; Halama, Niels; Pawlita, Michael; Waterboer, Tim; Eichmüller, Stefan B; Jäger, Dirk; Eggermont, Alexander M M; Zörnig, Inka